nafamostat: Clinical Trials

6 trials of nafamostat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 3, Not yet recruiting 2, Unknown 1

Follow nafamostat: new trials by email Literature Review of nafamostat trials Research Report on nafamostat

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
Citrate anticoagulation, Nafamostat Mesylate - Sepsis, Acute Kidney Injury
Phase 4Not yet recruitingJianfeng Xie11622026-06-102026-06-03
Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI
Nafamostat Mesylate, Unfractionated Heparin - Sepsis
Phase 4Not yet recruitingShen Lei1562024-04-012024-04-19
Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy
Nafamostat mesilate, 5% glucose - Sepsis, Sepsis-induced Coagulopathy
Phase 4UnknownXu Li7782023-10-012023-10-12
Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy
Nafamostat mesilate, Normal saline - Acute Kidney Injury
Phase 4CompletedKyungpook National University Hospital602010-07-012015-06-23
Effect of Nafamostat on Postreperfusion Syndrome (PRS)
Nafamostat, Normal saline - Liver Transplantation, Postreperfusion Syndrome
Phase 4CompletedSeoul National University Hospital622009-03-012010-05-11
The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy
Anticoagulation with nafamostat mesilate - Acute Kidney Injury
Phase 4CompletedYonsei University662007-09-012013-01-07

Conditions studied

Acute Kidney Injury (4)  ·  Sepsis (3)

Sponsors

Jianfeng Xie (1)  ·  Kyungpook National University Hospital (1)  ·  Seoul National University Hospital (1)  ·  Shen Lei (1)  ·  Xu Li (1)  ·  Yonsei University (1)

Countries

South Korea (2)  ·  China (1)

Top investigators

Chan-Duck Kim, M.D., PhD (1)  ·  Lei Shen, MD (1)  ·  Xu Li, Phd (1)  ·  Yingzi Huang (1)

Results publications

PMID 33314078, PMID 25302581, PMID 40731293